LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics, Inc. Investigated by the Portnoy Law Firm
LENZ Therapeutics (LENZ) had its price target lowered by HC Wainwright from $56.00 to $48.00. They now have a "buy" rating on the stock.
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
LENZ Therapeutics: Speculative But Strong Buy [Seeking Alpha]
The Consensus EPS Estimates For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Fell Dramatically [Yahoo! Finance]
Form ARS LENZ Therapeutics, Inc. For: Dec 31
Form DEFA14A LENZ Therapeutics, Inc.
Form DEF 14A LENZ Therapeutics, Inc. For: Jun 12
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: BlackRock, Inc.
Form SCHEDULE 13G LENZ Therapeutics, Inc. Filed by: Squarepoint Ops LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.